UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934.







Date of Report: February  01, 2005

(Date of earliest event reported)




LipidViro Tech, Inc.

(Exact name of registrant as specified in its charter)



NV

(State or other jurisdiction of incorporation)


 


000-49655

(Commission File Number)


 


870678927

(IRS Employer Indentification Number)




 


2120 South 700 East #H183

(Address of principal executive offices)


84106

(Zip Code)


 




Registrant's telephone number, including area code: 801-583-9900






Item 7.01. Regulation FD Disclosure





Item 9.01. Financial Statements and Exhibits

(c) Exhibits

99.1       Press Release of LipidViro Tech, Inc. dated February  01, 2005

1           Investor Presentation



SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be 
              signed on its behalf by the undersigned hereunto duly authorized.






Dated: February  01, 2005



LIPIDVIRO TECH, INC.

By:  /s/ Kenneth P. Hamik                      

     Kenneth P. Hamik

     CEO